TH131426A - Viral inhibitor composition for the therapeutic use of in vivo, consisting of (-) - carvone, (+) - carvone, geraniol ( Geraniol) and essential oil components. - Google Patents
Viral inhibitor composition for the therapeutic use of in vivo, consisting of (-) - carvone, (+) - carvone, geraniol ( Geraniol) and essential oil components.Info
- Publication number
- TH131426A TH131426A TH1201005038A TH1201005038A TH131426A TH 131426 A TH131426 A TH 131426A TH 1201005038 A TH1201005038 A TH 1201005038A TH 1201005038 A TH1201005038 A TH 1201005038A TH 131426 A TH131426 A TH 131426A
- Authority
- TH
- Thailand
- Prior art keywords
- carvone
- geraniol
- trans
- called
- methyl
- Prior art date
Links
- ULDHMXUKGWMISQ-VIFPVBQESA-N (+)-(4S)-carvone Chemical compound CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 title claims abstract 9
- 229930008393 geraniol Natural products 0.000 title claims abstract 8
- ULDHMXUKGWMISQ-SECBINFHSA-N (-)-(4R)-carvone Chemical compound CC(=C)[C@@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-SECBINFHSA-N 0.000 title claims 6
- 239000005792 Geraniol Substances 0.000 title 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 title 2
- 229940113087 geraniol Drugs 0.000 title 2
- GLZPCOQZEFWAFX-JXMROGBWSA-N β-Geraniol Chemical compound CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 title 2
- 239000003443 antiviral agent Substances 0.000 title 1
- 230000001225 therapeutic Effects 0.000 title 1
- 239000000341 volatile oil Substances 0.000 title 1
- 241000700605 Viruses Species 0.000 claims abstract 7
- GLZPCOQZEFWAFX-UHFFFAOYSA-N (E)-Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims abstract 6
- 230000000840 anti-viral Effects 0.000 claims abstract 2
- 239000000470 constituent Substances 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 230000002265 prevention Effects 0.000 claims abstract 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Natural products COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims 2
- NOOLISFMXDJSKH-LPEHRKFASA-N Isomenthol Natural products CC(C)[C@@H]1CC[C@H](C)C[C@H]1O NOOLISFMXDJSKH-LPEHRKFASA-N 0.000 claims 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propene Chemical compound CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 239000005973 Carvone Substances 0.000 abstract 1
- 229930007075 carvone Natural products 0.000 abstract 1
- 241001493065 dsRNA viruses Species 0.000 abstract 1
Abstract
DC60 (22/11/55) การประดิษฐ์ปัจจุบันเกี่ยวข้องกับองค์ประกอบต้านไวรัส (antiviral composition) ที่ประกอบ ด้วยส่วนประกอบที่ตามมา R-(-)-2-เมทิล-5-(พรอฟ-1-เอน-2-อิล)-ไซโคลเฮกซ-2-อิโนน (ด้วยเช่นกัน ถูกเรียกว่า (-) คาร์โวน (Carvone)) และ S-(+)-2- เมทิล-5-(พรอพ-1-เอน-2-อิล)-ไซโคลเฮกซ-2-อิโนน (ด้วยเช่นกัน ถูกเรียกว่า (+) คาร์โวน) และ (2E)-3,-7-ไดเมทิลออกทา-2,6-ไดเอน-1-ออล (ด้วยเช่นกัน ถูกเรียกว่า ทรานส์-เจรานิออล (trans-Geraniol)) ในการรวมกับอย่างน้อยอีกหนึ่งองค์ประกอบซึ่งถูก เลือกทามกลางส่วนประกอบน้ำมันที่จำเป็น สำหรับการใช้ในการรักษาและการป้องกันของโรคซึ่งถูก ทำให้เกิดขึ้นโดยไวรัสซึ่งห่อหุ้ม DNA, ไวรัสซึ่งไม่ห่อหุ้ม DNA, ไวรัสซึ่งห่อหุ้ม RNA และ ไวรัสซึ่ง ไม่ห่อหุ้ม RNA : สิทธิบัตรยา DC60 (11/22/55), the current invention involves the antiviral composition composed of subsequent components. R - (-) - 2-methyl-5- (prop-1-en-2-il) - cyclohex-2-inone (also called (-) carvo (Carvone)) and S - (+) - 2-methyl-5- (prop-1-en-2-il) - cyclohex-2-inone (also called (+) Carvone) and (2E) -3, -7-dimethyl octa-2,6-dien-1-all (also called trans-geraniol (trans-Geraniol)) in combination with at least one other constituent Choose between the necessary oil components. For use in the treatment and prevention of disease which was Caused by DNA-enveloped viruses, DNA-enveloped viruses, RNA-enveloped viruses, and non-encapsulated RNA viruses: drug patent.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH131426B TH131426B (en) | 2014-02-27 |
| TH131426A true TH131426A (en) | 2014-02-27 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA102497C2 (en) | Antiviral compositions for therapeutic use in vivo containing (-)-carvone, (+)-carvone, geraniol and in combination with essential oil component | |
| BRPI1013394A2 (en) | "compound, pharmaceutical composition, use of the compound, and method for treating a hepatitis c virus infected patient." | |
| EA201290982A1 (en) | PHARMACEUTICAL COMPOSITIONS, PREVENTING ABUSE | |
| ECSP099685A (en) | SULFUR COMPOUNDS AS INHIBITORS OF THE SERINA PROTEASA NS3 OF THE HEPATITIS C VIRUS | |
| JP2014533241A5 (en) | ||
| BR112015007879A2 (en) | hepatitis c virus inhibitors | |
| EA201590790A1 (en) | STABLE PHARMACEUTICAL COMPOSITION BASED ON PEG-INTERFERON ALPHA-2b | |
| BR112014015582A8 (en) | antiviral compounds | |
| TH131426A (en) | Viral inhibitor composition for the therapeutic use of in vivo, consisting of (-) - carvone, (+) - carvone, geraniol ( Geraniol) and essential oil components. | |
| TH131426B (en) | Viral inhibitor composition for therapeutic use. Diseases within living organisms consist of the combination of (-) - carvone, (+) - carvone, Geraniol and essential oil components. | |
| UA117563C2 (en) | Composition for treating cancer associated with hpv infection | |
| Liebman | Mediterranean mix-up: what a new study did--and didn't--find | |
| WO2012140666A3 (en) | Herbal extracts and compositions prepared therefrom | |
| Davodimoghadam et al. | The Stylistic of Post Modern Ghazal | |
| Jeong | DUCK's Column | |
| Bakhtikireyeva | Tlostanova MV Gender Epistemologies and Eurasian Borderlands | |
| Романів | Autodestructive aspects of myocardial infarction | |
| TH1601005909A (en) | Anti-sensitivity ingredients for teeth | |
| TH169698A (en) | 4-hydroxy-2-methyl-5- (propan-2-ilidine) cyclohex-3-encarbaldehyde For the prevention and treatment of cognitive disorders or disorders, neurological or neurological deterioration | |
| TH177971A (en) | Composition for promoting hair growth or hair regeneration and for anti-inflammatory | |
| TH1601003516A (en) | A gradual release pharmaceutical constituents that contain acbrophylline and its metabolites. Release the drug gradually, hydrophobic | |
| RU2015131648A (en) | 2- [2- (3-CHLORODAMANTHAN-1-IL) -2-OXOETHYLIDENEHYDRAZINO] -4- (2, 4-DIMETHOXYPHENYL) -4-OXO-2-BUTENIC ACID, POSSESSING ANTIFAVIVIRUS VIRUS | |
| TH1701002657A (en) | Constituents containing naracin for the treatment of viral infections. | |
| CL2013002761A1 (en) | Use of pharmaceutical composition comprising catechols (1,2-dihydroxybenzenes) 3,5 disubstituted, useful for the treatment of diseases caused by DNA or encapsulated (non) RNA virus. | |
| TH158445A (en) | Recombinant Coyherpes Virus (KHV) and Vaccine for the prevention of disease induced by KHV. |